Recurrent gray-zone lymphoma

Clinical trials for Recurrent gray-zone lymphoma explained in plain language.

Never miss a new study

Get alerted when new Recurrent gray-zone lymphoma trials appear

Sign up with your email to follow new studies for Recurrent gray-zone lymphoma, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Not yet finished but already full! 2 Completed 1

New drug cocktail shows promise for Tough-to-Treat lymphoma

Disease control Completed

This early-stage trial tested a combination of two drugs, lenalidomide and blinatumomab, in 35 adults with non-Hodgkin lymphoma that had come back or stopped responding to treatment. The main goal was to find the safest dose and understand side effects. Researchers also looked at…

Matched conditions: RECURRENT GRAY-ZONE LYMPHOMA

Phase 1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Jun 27, 2026 08:00 UTC

Recurrent gray-zone lymphoma

Get alerted when new Recurrent gray-zone lymphoma trials appear

New drug cocktail shows promise for Tough-to-Treat lymphoma